Interview with the Innovators

Interview with the Innovators

Video Library | June 21, 2021
Combination therapy continues to evolve in the renal-cell carcinoma space. However, along with improved efficacy come the tests of adverse events and their impact on quality of life. Please join Laura Wood, RN, MSN, OCN, Virginia Seery, MSN, RN, ANP-BC, AOCNP, and Megan Price, MSN, APRN, FNP-C, as they discuss the ways in which drug combinations improve outcomes but also present their own set of challenges for patients’ quality of life.
June 2021 Vol 12, No 6 | June 16, 2021
What makes an effective navigation program? Intrinsically, you know the answer to this question. But practically, it can be difficult to prove effectiveness. Unless, of course, you have the right tools.
June 2021 Vol 12, No 6 | June 16, 2021
CHS offers a vast network of care locations that include outpatient, surgical and rehabilitation centers, physician practices, behavioral health, occupational health, home care, a medically based fitness center, as well as the Community Cancer Research Foundation and the Cancer Resource Centre.
Video Library | June 15, 2021
Identification of new actionable targets and driver mutations have revolutionized the treatment of NSCLC
Video Library | June 2, 2021
There are an ever-growing number of treatment options that are contributing to more successful outcomes and higher survival rates for cancer patients. The number of care providers that cancer patients need during their journey is also expanding. Please join Laura Wood, RN, MSN, OCN, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they discuss the role of the multidisciplinary care team approach to deliver the best possible treatment for cancer patients.
Video Library | May 26, 2021
Nephrectomy is often the initial treatment for renal-cell cancer (RCC), but systemic therapy is frequently required for advanced RCC. Single-agent targeted therapies are only somewhat effective, which led to the development of immunotherapies and combination therapies (which include immunotherapies). Laura Wood, RN, MSN, OCN, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss the clinical advantages of combination therapies in patients with advanced RCC.
Video Library | May 7, 2021
Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss their roles and responsibilities within their academic oncology centers as valuable members of a multidisciplinary team that helps patients successfully navigate the spectrum of patient care. They also detail how they apply the principles of patient-centered care to improve outcomes for patients.

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State
  • Please enter your mailing address.

    Address Line 2
    Zip Code